Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Pasetto, Silvana ^a   Pardi, Vanessa ^a   Murata, Ramiro Mendonça ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MICROBICIDE; MYRICETIN; PINOCEMBRINE; QUERCETIN; RNA DIRECTED DNA POLYMERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; FLAVANONE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; ENZYME INHIBITION; FEMALE GENITAL TRACT INFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC50; IN VITRO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; VIRUS INHIBITION; VIRUS STRAIN; BIOLOGICAL MODEL; DRUG EFFECTS; FEMALE; FEMALE GENITAL SYSTEM; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI-HIV AGENTS; FEMALE; FLAVANONES; FLAVONOIDS; GENITALIA, FEMALE; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL; QUERCETIN;

EID: 84919926315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115323     Document Type: Article

References (60)

1. UNAIDS (2013) UNAIDS on the Global AIDS Epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS). Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS). pp.1-198.
2. UNAIDS (2012) UNAIDS. Together we will end AIDS. Joint United Nations Programme on HIV/AIDS (UNAIDS). Geneva, Swtzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS). pp.1-135.
3. Coombs RW, Reichelderfer PS, Landay AL (2003) Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 17: 455-480.
4. Royce RA, Sena A, Cates W, Jr., Cohen MS (1997) Sexual transmission of HIV. N Engl J Med 336: 1072-1078.
5. Cutler B, Justman J (2008) Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis 8: 685-697.
6. Arien KK, Jespers V, Vanham G (2011) HIV sexual transmission and microbicides. Rev Med Virol.
7. Bomsel M (1997) Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 3: 42-47.
8. D'Cruz OJ, Uckun FM (2004) Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des 10: 315-336.
9. NIH (2012) NIH. Fiscal Year 2013 Trans-NIH AIDS research by-pass bugdet estimate and trans-NIH plan for HIV-related research in: Area of emphasis microbicides. In: Health NIo, editor. Bethesda, USA: NIH. pp.77.
10. Stone A (2010) Regulatory Issues in Microbicide Development. Geneva: World Health Organization. 62 p.
11. Di Stasi LC, Oliveira GP, Carvalhaes MA, Queiroz M Jr., Tien OS, et al. (2002) Medicinal plants popularly used in the Brazilian Tropical Atlantic Forest. Fitoterapia 73: 69-91.
12. Basso LA, da Silva LH, Fett-Neto AG, de Azevedo WF, Jr., Moreira Ide S, et al. (2005) The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases-a review. Mem Inst Oswaldo Cruz 100: 475-506.
13. Yu YB, Miyashiro H, Nakamura N, Hattori M, Park JC (2007) Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes. Arch Pharm Res 30: 820-826.
14. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, et al. (2005) In vivo quercitrin antiinflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35: 584-592.
15. Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32: 1141-1148.
16. Kandaswami C, Middleton E, Jr. (1994) Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 366: 351-376.
17. Mehla R, Bivalkar-Mehla S, Chauhan A (2011) A flavonoid, luteolin, cripples HIV-1 by abrogation of tat function. PLoS One 6: e27915.
18. Middleton E, Jr., Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
19. Montefiori DC (2009) Measuring HIV neutralization in a luciferase reporter gene assay. Methods Mol Biol 485: 395-405.
20. Wood KV (1990) Luc genes: introduction of colour into bioluminescence assays. J Biolumin Chemilumin 5: 107-114.
21. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, et al. (2005) Human immunodeficiency virus type env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79: 10108-10125.
22. Popovic M GS, Read-Connole E, Beaver B, Reitz M. (1989) Cell tropism and expression of HIV-1 isolates in natural targets. In: Valette Ga, editor. Retroviruses of Human AIDS and Related Animal Diseases, Colloque Des Cent GardesParis: Marnes-La0Coquette. pp.21-27.
23. Reitz MS, Jr., Guo HG, Oleske J, Hoxie J, Popovic M, et al. (1992) On the historical origins of HIV-1 (MN) and (RF). AIDS Res Hum Retroviruses 8: 1950.
24. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, et al. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500-503.
25. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. (1992) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66: 7517-7521.
26. Richman DD, Johnson VA, Mayers DM, Shirasaka T, O'Brien MC, et al. (2001) In vitro evaluation of experimental agents for anti-HIV activity. Curr Protoc Immunol Chapter 12: Unit 12 19.
27. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267: 5421-5426.
28. Ochsenbauer-Jambor C, Jones J, Heil M, Zammit KP, Kutsch O (2006) T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication. Biotechniques 40: 91-100.
29. Gurgo C, Guo HG, Franchini G, Aldovini A, Collalti E, et al. (1988) Envelope sequences of two new United States HIV-1 isolates. Virology 164: 531-536.
30. Goncalves MA, Janssen JM, Holkers M, de Vries AA (2010) Rapid and sensitive lentivirus vectorbased conditional gene expression assay to monitor and quantify cell fusion activity. PLoS One 5: e10954.
31. Rajotte D, Tremblay S, Pelletier A, Salois P, Bourgon L, et al. (2013) Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series. Antimicrob Agents Chemother 57: 2712-2718.
32. Tan GT, Pezzuto JM, Kinghorn AD, Hughes SH (1991) Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod 54: 143-154.
33. Arien KK, Vanham G, Gali Y (2011) A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides. Curr Protoc Cell Biol Chapter 26: Unit26 13.
34. Gali Y, Arien KK, Praet M, Van den Bergh R, Temmerman M, et al. (2010) Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity. J Virol Methods 165: 186-197.
35. Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75: 311-335.
36. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, et al. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386.
37. Schnitzler P, Neuner A, Nolkemper S, Zundel C, Nowack H, et al. (2010) Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother Res 24 Suppl 1:S20-28.
38. Lyu SY, Rhim JY, Park WB (2005) Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res 28: 1293-1301.
39. Gordon MH, Roedig-Penman A (1998) Antioxidant activity of quercetin and myricetin in liposomes. Chem Phys Lipids 97: 79-85.
40. Santos AC, Uyemura SA, Lopes JL, Bazon JN, Mingatto FE, et al. (1998) Effect of naturally occurring flavonoids on lipid peroxidation and membrane permeability transition in mitochondria. Free Radic Biol Med 24: 1455-1461.
41. Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, et al. (1999) Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr 69: 87-94.
42. Sala A, Recio MC, Schinella GR, Manez S, Giner RM, et al. (2003) Assessment of the antiinflammatory activity and free radical scavenger activity of tiliroside. Eur J Pharmacol 461: 53-61.
43. Sharma R, Kishore N, Hussein A, Lall N (2013) Antibacterial and anti-inflammatory effects of Syzygium jambos L. (Alston) and isolated compounds on acne vulgaris. BMC Complement Altern Med 13: 292.
44. Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay O, et al. (2005) Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol Res 160: 189-195.
45. Kim ME, Ha TK, Yoon JH, Lee JS (2014) Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. Anticancer Research 34: 701-706.
46. Lee KW, Kang NJ, Rogozin EA, Kim HG, Cho YY, et al. (2007) Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 28: 1918-1927.
47. Ataher Q, Portsmouth S, Napolitano LA, Eng S, Greenacre A, et al. (2012) The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa. J Int AIDS Soc 15.
48. De Clercq E (2010) Antiretroviral drugs. Curr Opin Pharmacol 10: 507-515.
49. Richman DD (2006) Antiviral drug resistance. Antiviral Res 71: 117-121.
50. Nijhuis M, van Maarseveen NM, Boucher CA (2009) Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Handb Exp Pharmacol: 299-320.
51. Li BQ, Fu T, Yao DY, Mikovits JA, Ruscetti FW, et al. (2000) Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun 276: 534-538.
52. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, et al. (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 48: 595-608.
53. Kim HJ, Woo ER, Shin CG, Park H (1998) A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase. J Nat Prod 61: 145-148.
54. Critchfield JW, Butera ST, Folks TM (1996) Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retroviruses 12: 39-46.
55. Marquez N, Sancho R, Bedoya LM, Alcami J, Lopez-Perez JL, et al. (2005) Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Antiviral Res 66: 137-145.
56. Lee-Huang S, Zhang L, Huang PL, Chang YT, Huang PL (2003) Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun 307: 1029-1037.
57. Ono K, Nakane H (1990) Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J Biochem 108: 609-613.
58. Van Herrewege Y, Michiels J, Waeytens A, De Boeck G, Salden E, et al. (2007) A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides. Antiviral Res 74: 111-124.
59. Abdool Karim Q, Sibeko S, Baxter C (2010) Preventing HIV infection in women: a global health imperative. Clin Infect Dis 50 Suppl 3:S122-129.
60. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.